Oxytocin, as the neurohormone associated with care behavior, is implicated in the pathophysiology of MDD in humans (Engel et al., 2019), too, and it is a potential candidate for explaining treatment outcomes in relation to patient–therapist synchrony. This evidence concerns the gene OXT and major depressive disorder.